-
Leman Biotech Secures Over USD 13.9 Million in Series A Financing for Next-Gen Cancer Immunotherapies
•
China-based Leman Biotech Co., Ltd. has reportedly completed the first closing of its Series A financing round, raising over RMB 100 million (USD 13.9 million). The round was led by Fuho Capital, with additional contributions from Jun Yi Investment and AI-driven drug R&D leader XtalPi. The funds will be directed…
-
XtalPi’s AI Platform XtalFold Secures Licensing Deal with Janssen Biotech, Enhancing Biologics Discovery
•
XtalPi Inc., a leading AI-driven drug discovery firm based in Shenzhen and known as QuantumPharm Inc. (HKG: 2228), has announced a significant licensing agreement with Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, for its proprietary AI platform, Ailux Biologics’ XtalFold. This platform, recognized for its innovative approach in…
-
Xtalpi Inc. Makes a Splash with HKD 1.13 Billion IPO on Hong Kong Stock Exchange
•
QuantumPharm Inc., operating under the name Xtalpi Inc., has successfully conducted an initial public offering (IPO) on the Hong Kong Stock Exchange, raising HKD 1.13 billion (USD 144.5 million). The shares of Xtalpi, listed under the ticker symbol 02228, were priced at HKD 6.03 per share. Xtalpi is a pioneer…
-
XtalPi Forms Strategic Partnership with ABB Robotics to Automate Lab Workstations in China
•
Sino-US AI drug development company XtalPi has entered into a strategic partnership with Switzerland-based ABB Robotics, aiming to manufacture a series of automated laboratory workstations within China. These workstations, featuring ABB’s GoFa robots, are anticipated to enhance the productivity of R&D processes across biopharmaceuticals, chemical engineering, chemistry, and new energy…
-
XtalPi Partners with University of Hong Kong’s ABIC to Advance Biomedical Technology Commercialization
•
XtalPi Inc., a Sino-U.S. artificial intelligence firm, has signed a memorandum of understanding (MOU) with the Advanced Biomedical Instrumentation Centre (ABIC) at the University of Hong Kong (UHK) to foster collaboration aimed at enhancing research and commercial applications of ABIC’s technological advancements both locally and internationally. Under the terms of…
-
XtalPi Inc. and Singapore’s EDDC Broaden Collaboration in AI-Driven Drug Discovery
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has entered into a memorandum of understanding (MOU) with the Experimental Drug Development Centre (EDDC) in Singapore to form a collaborative partnership. The two entities have pledged to expand their collaboration to include the application of automated synthesis experiments and large language models…
-
XtalPi Inc. and CK Life Sciences Expand Partnership to Develop AI-Powered Cancer Diagnostics
•
Sino-US artificial intelligence (AI) firm XtalPi Inc. has announced a strategic partnership agreement with China-based CK Life Sciences (HKG: 0775). The collaboration aims to leverage AI and clinical diagnosis data, including biomarker information from cancer patients and healthy populations, to develop molecular diagnostic models that predict cancer prognosis risk based…
